Systematic analysis of factors influencing observations of biased agonism at the mu-opioid receptor.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Biochemical Pharmacology

• Publication date

  2016-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bcp.2016.05.014PMID 27286929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantifying biased signaling in GPCRs using BRET-based biosensors.

  2016cited by this paper
• The role of kinetic context in apparent biased agonism at GPCRs

  2016cited by this paper
• N-linked glycosylation of protease-activated receptor-1 at extracellular loop 2 regulates G-protein signaling bias

  2015cited by this paper
• Intrinsic relative activities of κ opioid agonists in activating Gα proteins and internalizing receptor: Differences between human and mouse receptors.

  2015cited by this paper
• Biased Agonism of Endogenous Opioid Peptides at the μ-Opioid Receptor

  2015cited by this paper
• Biased Signaling at Chemokine Receptors*

  2015cited by this paper
• The Effective Application of Biased Signaling to New Drug Discovery

  2015cited by this paper
• Novel GPCR paradigms at the μ‐opioid receptor

  2015cited by this paper
• Identification of Novel Functionally Selective κ-Opioid Receptor Scaffolds

  2014cited by this paper
• Quantification of Ligand Bias for Clinically Relevant β2-Adrenergic Receptor Ligands: Implications for Drug Taxonomy

  2014cited by this paper
• What is biased efficacy? Defining the relationship between intrinsic efficacy and free energy coupling.

  2014cited by this paper
• Structure-activity relationships of privileged structures lead to the discovery of novel biased ligands at the dopamine D₂ receptor.

  2014cited by this paper
• Endocytic Profiles of δ-Opioid Receptor Ligands Determine the Duration of Rapid but Not Sustained cAMP Responses

  2014cited by this paper
• Differentiation of Opioid Drug Effects by Hierarchical Multi-Site Phosphorylation

  2013cited by this paper
• Differential Activation and Modulation of the Glucagon-Like Peptide-1 Receptor by Small Molecule Ligands

  2013cited by this paper
• Conformational biosensors reveal GPCR signalling from endosomes

  2013cited by this paper
• Ligand- and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists

  2013cited by this paper
• Biased Agonism as a Mechanism for Differential Signaling by Chemokine Receptors*

  2013cited by this paper
• Compartmentation of cAMP signalling in cardiomyocytes in health and disease

  2013cited by this paper
• Deciphering µ‐opioid receptor phosphorylation and dephosphorylation in HEK293 cells

  2012cited by this paper
• Endomorphin-2: A Biased Agonist at the μ-Opioid Receptor

  2012cited by this paper
• Fluorescence/Bioluminescence Resonance Energy Transfer Techniques to Study G-Protein-Coupled Receptor Activation and Signaling

  2012cited by this paper
• A simple method for quantifying functional selectivity and agonist bias.

  2012cited by this paper
• Signalling bias in new drug discovery: detection, quantification and therapeutic impact

  2012cited by this paper
• Discovery of β-Arrestin–Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy

  2011cited by this paper
• Choreographing the adenylyl cyclase signalosome: sorting out the partners and the steps

  2011cited by this paper
• Scikit-learn: Machine Learning in Python

  2011cited by this paper
• Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis

  2011cited by this paper
• Quantification of Functional Selectivity at the Human α1A-Adrenoceptor

  2011cited by this paper
• Histidine 6.55 Is a Major Determinant of Ligand-Biased Signaling in Dopamine D2L Receptor

  2011cited by this paper
• Differential modulation of mu‐opioid receptor signaling to adenylyl cyclase by regulators of G protein signaling proteins 4 or 8 and 7 in permeabilised C6 cells is Gα subtype dependent

  2010cited by this paper
• Morphine-like Opiates Selectively Antagonize Receptor-Arrestin Interactions*

  2010cited by this paper
• Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu- and delta-opioid receptor signaling.

  2009cited by this paper
• Persistent cAMP-Signals Triggered by Internalized G-Protein–Coupled Receptors

  2009cited by this paper
• Agonist-selective, Receptor-specific Interaction of Human P2Y Receptors with β-Arrestin-1 and -2*

  2008cited by this paper
• Endogenous Regulators of G Protein Signaling Differentially Modulate Full and Partial μ-Opioid Agonists at Adenylyl Cyclase as Predicted by a Collision Coupling Model

  2008cited by this paper
• Functional Selectivity and Classical Concepts of Quantitative Pharmacology

  2007cited by this paper
• Ligand-specific receptor states: implications for opiate receptor signalling and regulation.

  2007cited by this paper
• Use of a cAMP BRET Sensor to Characterize a Novel Regulation of cAMP by the Sphingosine 1-Phosphate/G13 Pathway*

  2007cited by this paper
• Comparison of the Relative Efficacy and Potency of μ-Opioid Agonists to Activate Gαi/o Proteins Containing a Pertussis Toxin-Insensitive Mutation

  2006cited by this paper
• Agonist-Selective Mechanisms of μ-Opioid Receptor Desensitization in Human Embryonic Kidney 293 Cells

  2006cited by this paper
• Distinct Signaling Profiles of β1 and β2 Adrenergic Receptor Ligands toward Adenylyl Cyclase and Mitogen-Activated Protein Kinase Reveals the Pluridimensionality of Efficacy

  2006cited by this paper
• Differential activation of G‐proteins by μ‐opioid receptor agonists

  2006cited by this paper
• Opioid Agonists Have Different Efficacy Profiles for G Protein Activation, Rapid Desensitization, and Endocytosis of Mu-opioid Receptors*

  2003cited by this paper
• Agonists activate Gi1 alpha or Gi2 alpha fused to the human mu opioid receptor differently.

  2002cited by this paper
• Differential effects of mu-opioid receptor ligands on Ca(2+) signaling.

  2002cited by this paper
• Agonists activate Gi1α or Gi2α fused to the human mu opioid receptor differently

  2002cited by this paper
• Differential Effects of (cid:1) -Opioid Receptor Ligands on Ca 2 (cid:1) Signaling

  2002cited by this paper
• Rapid kinetics of regulator of G-protein signaling (RGS)-mediated Galphai and Galphao deactivation. Galpha specificity of RGS4 AND RGS7.

  2000cited by this paper
• Coupling Efficacy and Selectivity of the Human μ‐Opioid Receptor Expressed as Receptor—Gα Fusion Proteins in Escherichia coli

  2000cited by this paper
• Rapid Kinetics of Regulator of G-protein Signaling (RGS)-mediated Gαi and Gαo Deactivation

  2000cited by this paper
• Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness.

  1998cited by this paper
• Assessing the distribution of parameters in models of ligand-receptor interaction: to log or not to log.

  1998cited by this paper
• Carboxyl-terminal Splicing of the Rat μ Opioid Receptor Modulates Agonist-mediated Internalization and Receptor Resensitization*

  1998cited by this paper
• Distinct patterns of bidirectional regulation of mammalian adenylyl cyclases.

  1994cited by this paper
• Inhibition of adenylyl cyclase by Gi alpha.

  1993cited by this paper
• Inhibition of cloned adenylyl cyclases by mutant-activated Gi-alpha and specific suppression of type 2 adenylyl cyclase inhibition by phorbol ester treatment.

  1993cited by this paper
• Estimation of agonist affinity and efficacy by direct, operational model-fitting.

  1990cited by this paper
• Fitting curves to data using nonlinear regression: a practical and nonmathematical review

  1987cited by this paper
• Principal component analysis

  1987cited by this paper
• Mu and delta receptors belong to a family of receptors that are coupled to potassium channels.

  1987cited by this paper
• Operational models of pharmacological agonism

  1983cited by this paper

• Unveiling Dopamine and Met-Enkephalin Dynamics: Simultaneous Co-Detection in Rat Striatum.

  2025cites this paper
• Antidepressants and the endogenous opioid system.

  2025cites this paper
• Electrochemical Quantification of Enkephalin Peptides Using Fast-Scan Cyclic Voltammetry.

  2024cites this paper
• Ketamine and Major Ketamine Metabolites Function as Allosteric Modulators of Opioid Receptors

  2024cites this paper
• Current strategic trends in drug discovery: the present as prologue

  2023cites this paper
• Biased Agonism: Lessons from Studies of Opioid Receptor Agonists.

  2022cites this paper
• The life and times of endogenous opioid peptides: Updated understanding of synthesis, spatiotemporal dynamics, and the clinical impact in alcohol use disorder

  2022cites this paper
• Quantifying the Kinetics of Signaling and Arrestin Recruitment by Nervous System G-Protein Coupled Receptors

  2022influential citation
• Buprenorphine: Far Beyond the “Ceiling”

  2021cites this paper
• Central blockade of orexin type 1 receptors reduces the naloxone induced activation of locus coeruleus neurons in the morphine dependent rats.

  2021cites this paper
• A novel luminescence-based β-arrestin recruitment assay for unmodified receptors

  2021cites this paper
• Biased signaling by endogenous opioid peptides

  2020cites this paper
• A novel luminescence-based β-arrestin membrane recruitment assay for unmodified GPCRs

  2020cites this paper
• Signaling diversity of mu- and delta- opioid receptor ligands: Re-evaluating the benefits of β-arrestin/G protein signaling bias.

  2020influential citation
• Heteromerization of Endogenous Mu and Delta Opioid Receptors Induces Ligand-Selective Co-Targeting to Lysosomes

  2020cites this paper
• Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists

  2020cites this paper
• Mu opioid receptor in microglia contributes to morphine analgesic tolerance, hyperalgesia, and withdrawal in mice

  2020cites this paper
• Morphine-induced respiratory depression is independent of -arrestin2 signalling. British

  2020cites this paper
• Biased agonism of clinically approved μ-opioid receptor agonists and TRV130 is not controlled by binding and signaling kinetics.

  2020cites this paper
• Morphine‐induced respiratory depression is independent of β‐arrestin2 signalling

  2020cites this paper
• Opioid Pharmacology under the Microscope

  2020cites this paper
• A tetrapeptide class of biased analgesics from an Australian fungus targets the µ-opioid receptor

  2019cites this paper
• Current strategies toward safer mu opioid receptor drugs for pain management

  2019cites this paper
• The in vivo antinociceptive and μ-opioid receptor activating effects of the combination of N-phenyl-2',4'-dimethyl-4,5'-bi-1,3-thiazol-2-amines and naloxone.

  2019cites this paper
• Applications and limitations of fitting of the operational model to determine relative efficacies of agonists

  2019cites this paper
• Biased Receptor Signaling in Drug Discovery

  2019cites this paper
• A Biased View of μ-Opioid Receptors?

  2019cites this paper
• Design and biological assessment of membrane-tethering neuroprotective peptides derived from the pituitary adenylate cyclase-activating polypeptide type 1 receptor.

  2019cites this paper
• Discovery of Novel Biased Opioid Receptor Ligands through Structure‐Based Pharmacophore Virtual Screening and Experiment

  2019cites this paper
• Emergent Concepts of Receptor Pharmacology.

  2019cites this paper
• The Role of Opioid Receptors in Immune System Function

  2019cites this paper
• Major: Biological Sciences Pharmacology Biased μ-opioid analgesics derived from a novel tetrapeptide class found in an Australian fungus

  2019cites this paper
• Fluorescently Labeled Morphine Derivatives for Bioimaging Studies.

  2018cites this paper
• Temporal dependence of shifts in mu opioid receptor mobility at the cell surface after agonist binding observed by single-particle tracking

  2018cites this paper
• Endogenous Opiates and Behavior: 2016.

  2018cites this paper
• Heteromerization of endogenous mu and delta opioid receptors tunes mu opioid receptor signaling and trafficking

  2018cites this paper
• GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures

  2018cites this paper
• Real‐time examination of cAMP activity at relaxin family peptide receptors using a BRET‐based biosensor

  2018cites this paper
• Mechanisms of signalling and biased agonism in G protein-coupled receptors

  2018cites this paper
• Pharmacological property optimization for allosteric ligands: A medicinal chemistry perspective.

  2017cites this paper
• Biased mu‐opioid receptor ligands: a promising new generation of pain therapeutics

  2017cites this paper
• Mu-Opioid receptor biased ligands: A safer and painless discovery of analgesics?

  2017cites this paper
• Functional selectivity and dualsteric/bitopic GPCR targeting

  2017cites this paper
• Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design.

  2017cites this paper
• Analyzing biased responses of GPCR ligands.

  2017cites this paper
• Factors influencing biased agonism in recombinant cells expressing the human α1A‐adrenoceptor

  2017cites this paper
• β-Arrestin biased dopamine D2 receptor partial agonists: Synthesis and pharmacological evaluation.

  2017cites this paper
• Functional selectivity at G‐protein coupled receptors: Advancing cannabinoid receptors as drug targets

  2017cites this paper
• Measuring G protein‐coupled receptor signalling in the brain with resonance energy transfer based biosensors

  2017cites this paper
• Distinct roles of exogenous opioid agonists and endogenous opioid peptides in the peripheral control of neuropathy-triggered heat pain

  2016cites this paper
• A Pluridimensional View of Biased Agonism

  2016influential citation